These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26239274)

  • 21. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
    Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
    Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells.
    Zheng J; Liu Q; Li Y; Yang J; Ma J; Yu F; Shi H; Ren Q; Zhang R; Zhang J; Xue Y; Tao Y; Jiang N; Guo H; Yao L; Liu W
    Asian Pac J Cancer Prev; 2010; 11(6):1817-21. PubMed ID: 21338239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.
    Kang F; Wang Y; Luo Y; Zhang Y
    J Ovarian Res; 2020 Apr; 13(1):48. PubMed ID: 32345304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Role of Dickkopf-Related Protein 3 in Macropinocytosis in Human Bladder Cancer T24 Cells.
    Tsujimura N; Yamada NO; Kuranaga Y; Kumazaki M; Shinohara H; Taniguchi K; Akao Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.
    Andries V; Vandepoele K; Staes K; Berx G; Bogaert P; Van Isterdael G; Ginneberge D; Parthoens E; Vandenbussche J; Gevaert K; van Roy F
    BMC Cancer; 2015 May; 15():391. PubMed ID: 25958384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.
    Ma Y; Wu L; Liu X; Xu Y; Shi W; Liang Y; Yao L; Zheng J; Zhang J
    Oncol Rep; 2017 Aug; 38(2):975-984. PubMed ID: 28656310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.
    Liu N; Wang L; Liu X; Yang Q; Zhang J; Zhang W; Wu Y; Shen L; Zhang Y; Yang A; Han H; Zhang J; Yao L
    Biochem Biophys Res Commun; 2007 Jun; 358(1):164-9. PubMed ID: 17470364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated NDRG2 inhibits the proliferation of human renal cell carcinoma cell line OS-RC-2 in vitro.
    Qiang S; Du ZF; Huang M
    Asian Pac J Trop Med; 2014 Nov; 7(11):873-8. PubMed ID: 25441986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells.
    Li HL; Zhang S; Wang Y; Liang RR; Li J; An P; Wang ZM; Yang J; Li ZF
    Mol Med Rep; 2013 Jan; 7(1):266-70. PubMed ID: 23064738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts.
    Peng CC; Chen KC; Peng RY; Su CH; Hsieh-Li HM
    Cancer Lett; 2006 Nov; 243(1):109-19. PubMed ID: 16455193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Growth inhibition and mechanisms of human bladder cancer T24 cells by adenovirus-mediated ING4 gene in vitro].
    Zhang ZG; Ouyang J; Han CH; Yang JC; Yang HC; Long JH; Ding X
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(42):3008-13. PubMed ID: 21211316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil).
    Savio AL; da Silva GN; de Camargo EA; Salvadori DM
    Mutat Res; 2014 Apr; 762():40-6. PubMed ID: 24625788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells.
    Yan K; Zhang C; Feng J; Hou L; Yan L; Zhou Z; Liu Z; Liu C; Fan Y; Zheng B; Xu Z
    Eur J Pharmacol; 2011 Jul; 661(1-3):1-7. PubMed ID: 21545798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA‑663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2.
    Chen J; Song B; Kong G
    Mol Med Rep; 2019 May; 19(5):3896-3902. PubMed ID: 30896880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways.
    Ouyang J; Wu M; Huang C; Cao L; Li G
    Oncol Rep; 2013 Jan; 29(1):79-86. PubMed ID: 23124592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fucoxanthin induces growth arrest and apoptosis in human bladder cancer T24 cells by up-regulation of p21 and down-regulation of mortalin.
    Wang L; Zeng Y; Liu Y; Hu X; Li S; Wang Y; Li L; Lei Z; Zhang Z
    Acta Biochim Biophys Sin (Shanghai); 2014 Oct; 46(10):877-84. PubMed ID: 25187415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.